Jenchin Wang

Dr. Jenchin Wang

Brookdale University Hospital and Medical Center, Brooklyn, Connecticut, USA
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Leukemia Research
Verified
Journal Article
Closed access
JWJenchin Wang
Jenchin Wang
AKAjay Kundra
Ajay Kundra
MAMirela Andrei
Mirela Andrei
SBStacey Baptiste
Stacey Baptiste
CCChi Chen
Chi Chen
HSHemant Sindhu
Hemant Sindhu

12 February 2023 in European Journal of Haematology
Verified
Journal Article
Closed access
APAkriti Pokhrel
Akriti Pokhrel
OAOlayemi Adeniran
Olayemi Adeniran
SOStephanie Ogbonda
Stephanie Ogbonda
KNKiron Nair
Kiron Nair
JWJenchin Wang
Jenchin Wang

Verified
Journal Article
Open access
PDF file
JWJenchin Wang
Jenchin Wang
LSLishi Sun
Lishi Sun
There has been significant progress in immune checkpoint inhibitor (CPI) therapy in many solid tumor types. However, only a single failed study has been published in treating Ph(-) myeloproliferative neoplasm (MPN). To make progress in CPI studies on this disease, herein, we review and summarize the mechanisms of activation of the PD-L1 promoter, which are as follows: (a) the extrinsic mechanism, which is activated by interferon gamma (IFN γ) by tumor infiltration lymphocytes (TIL) and NK cells; (b) the intrinsic mechanism of EGFR or PTEN loss resulting in the activation of the MAPK and AKT pathways and then stat 1 and 3 activation; and (c) 9p24 amplicon amplification, resulting in PD-L1 and Jak2 activation. We also review the literature and postulate that many of the failures of CPI therapy in MPN are likely due to excessive MDSC activities. We list all of the anti-MDSC agents, especially those with ruxolitinib, IMID compounds, and BTK inhibitors, which may be combined with CPI therapy in the future as part of clinical trials applying CPI therapy to Ph(-) MPN.

1 April 2017 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
AKAjay Kundra
Ajay Kundra
JWJenchin Wang
Jenchin Wang

1 April 2019 in Leukemia Research
Verified
Journal Article
Closed access
JWJenchin Wang
Jenchin Wang
CCChi Chen
Chi Chen
AKAjay Kundra
Ajay Kundra
SKSreenath Kodali
Sreenath Kodali
APAnita Pandey
Anita Pandey
STSophia Tribie
Sophia Tribie

31 December 2009 in Leukemia Research
Verified
Journal Article
Closed access
SKSrinivas Kodali
Srinivas Kodali
CCChi Chen
Chi Chen
CRChenthilmurugan Rathnasabapathy
Chenthilmurugan Rathnasabapathy
JWJenchin Wang
Jenchin Wang